AQ Biotech

Turku, Finland · Founded 2017 · Privately Held (backing)

Developer of a non-invasive health screening and monitoring system designed for early detection of various diseases, particularly urinary tract cancers, starting from prostate cancers. AQ Biotech is based in Turku, Finland and was founded in 2017. Its last reported valuation was $11.5 million in Apr 2025. It has raised $8.6 million.

Last reported valuation
$11.5M
Oct 2026
Priced at
—
Total raised
$8.6M
Last round
—

Who backs AQ Biotech?

4 investors
InvestorType
TekesOther
Corporatum—
Keksintösäätiö—
Newentures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AQ Biotech investors

4 investors are on record for AQ Biotech, including Tekes, Corporatum, Keksintösäätiö and Newentures.

Free account
More of AQ Biotech with a free account
  • ·Watch AQ Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 4 firms already write checks for companies like AQ Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View